Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions

Melanoma Research

Volumn 9, Issue 3, 1999, Pages 253-260

  Ciotti, P ^a   Pesce, G P ^a   Cafiero, F ^b   Rainero, M L ^b   Sementa, A ^b   Nicolo G ^b   Mela, G S ^a   Bagnasco, M ^a   Santi, P L ^b   Bianchi Scarra G ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cytokines; GM CSF; ICAM 1; Immunochemistry; In situ hybridization; Melanoma

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MELANOMA; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER;

EID: 0032860393     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199906000-00007     Document Type: Article

References (31)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
2. Ciprandi G, Pronzato C, Ricca V, Bagnasco M, Canonica GW. Evidence of intercellular adhesion molecule-1 expression on nasal epithelial cells in acute rhinoconjunctivitis caused by pollen exposure. J Allergy Clin Immunol 1994; 94: 738-746.
3. Bagnasco M, Caretto A, Olive D, et al. Expression of intercellular adhesion molecule-1 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer. Clin Exp Immunol 1991; 83: 309-313.
4. Gearing AJH, Newmann W. Circulating adhesion molecules in disease. Immunol Today 1993; 10: 506-512.
5. Pui CH, Luo X, Evans W, Martin S, Rugg A, Wilimas J, Crist WM, Hudson M. Serum intercellular adhesion molecule-1 in childhood malignancy. Blood 1993; 82: 895-898.
6. Altomonte M, Colizzi F, Esposito G, Maio M. Circulating intercellular adhesion molecule-1 as a marker of disease progression in cutaneous melanoma. N Engl J Med 1993; 327: 959.
7. Natali PG, Nicotra MR, Cavaliere R, Bigotti A, Romano G, Temponi M, Ferrone S. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990; 50: 1271-1278.
8. 3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 1997; 57: 1554-1560.
9. Giavazzi R, Garofalo A, Banie MR, Abbate M, Ghezzi P, Boraschi D, Mantovani A, Dejana E. Interleukin-1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 1990; 50: 4771-4775.
10. Kageshita T, Yoshii A, Kimura T, Kuriya N, Ono T, Tsujisaki M, Imai K, Ferrone S. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res 1993; 53:4927-4932.
11. Maio M, Gulwani B, Langer JA, Kerbel RS, Duigou GJ, Fisher PB, Ferrone S. Modulation by interferons of HLA antigen, high-molecular-weight-melanoma associated antigen, and intercellular adhesion molecule I expression by cultured melanoma cells with different metastatic potential. Cancer Res 1989; 49: 2980-2987.
12. Yoneda K, Mori S, Takemura M, Noma A, Yamamoto A. Intercellular adhesion molecule-1 on cultured human melanoma cells: influence of cytokines. J Dermatol 1993; 20: 114-150.
13. Fonsatti E, Altomonte M, Coral S, Cattarossi I, Nicotra MR, Gasparollo A, Natali PG, Maio M. Turnout-derived interleukin 1α (IL-1α) up-regulates the release of soluble intercellular adhesion molecule-1 (sICAM-1) by endothelial cells. Br J Cancer 1997; 76: 1255-1261.
14. Bernasconi S, Matteucci C, Sironi M, Conni M, Colotta F, Mosca M, Colombo N, Bonazzi C, Landoni F, Corbetta G, Mantovani A, Allavena P. Effect of granulocyte-monocyte colony-stimulating factor (GM-CSF) on expression of adhesion molecules and production of cytokines in blood monocytes and ovarian cancer-associated macrophages. Int J Cancer 1995; 60: 300-307.
15. Kohn EC, Hollister GH, Dipersio JD, Wahl S, Liotta LA, Schiffmann E. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer 1993; 53: 968-972.
16. Joraschkewitz M, Depenbrock H, Freund M, Erdmann G, Meyer HJ, De Riese W, Neukam D, Hanauske U, Krumwich M, Poliwoda H, Hanauske AR. Effects of cytokines on in vitro colony formation of primary human tumour specimens. Eur J Cancer 1996; 26: 1070.
17. Pavel P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A, Gerdin B, Kiessling R. Selective expression of interleukin 10, interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992; 89: 7708.
18. Young MRI, Schmidt-Pak A, Wright MA, Mattews JP, Collins SL, Petruzzelli G. Mechanism of immune suppression in patients with head and neck cancer: presence of immune suppressive CD34+ cells in cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1995; 1: 95.
19. Ciotti P, Imro A, Scudeletti M, Rainero ML, Defferrari R, Ghiorzo P, Indiveri F, Bianchi-Scarra G. MEL-P, a GM-CSF-producing human melanoma cell line. Melanoma Res 1996; 6: 203-213.
20. Ciotti P, Rainero ML, Nicolò G, Spina B, Garre C, Casabona F, Santi PL, Bianchi-Scarra G. Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res 1995; 5: 41-47.
21. Singh RK, Gutman M, Radinsky R. Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials. J Interferon Cytokine Res 1995; 15: 81-87.
22. Han D, Pottin-Clemenceau C, Imro MA, Scudeletti M, Doucet C, Puppo F, Brouty-Boye D, Vedrenne J, Saharoui Y, Brailly H, Poggi A, Jasmin C, Azzarone B, Indiveri F. IL-2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INF-alpha biotherapy. Oncogene 1996; 12: 1015-1023.
23. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-245.
24. Bagnasco M, Pesce G, Fiorino N, Riccio AM, Ciprandi G, Buscaglia S, Canonica GW. In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammation. Clin Exp Allergy 1997; 27: 737-74.
25. Velikova G, Banks RE, Gearing A, Hemingway I, Forbes MA, Preston SR, Jones M, Wyatt J, Miller K, Ward U, Al-Maskatti J, Singh SM, Ambrose NS, Primrose JN, Selby PJ. Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (I-CAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J Cancer 1997; 76: 1398-1404.
26. Tanaka Y, Fukudome K, Hayashi M, Takagi S, Yoshie O. Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines. Int J Cancer 1995; 60: 554-561.
27. Chadwick CC, Shaw LJ, Winneker RC. TNF-alpha and 9-cis-retinoic acid synergistically induce ICAM-1 expression: evidence for interaction of retinoid receptors with NF-kappa B. Exp Cell Res 1998; 239: 423-429.
28. Musso M, Ghiorzo P, Fiorentini P, Giuffrida R, Ciotti P, Garre C, Ravazzolo R, Bianchi-Scarra G. An upstream regulatory element in human GM-CSF promoter is recognized by NF-KB/Re1 family members. Biochem Biophys Res Commun 1996; 223: 64-72.
29. Armstrong CA, Botella R, Galloway TH, Murray N, Kramp JM, Song IS, Ansel JC. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res 1996; 56: 2191-2198.
30. 2-dependent and -independent immune suppressor cells by tumor-derived GM-CSF and M-CSE. J Leukocyte Biol 1993; 53: 86.
31. Wright MA, Wiers K, Vellody K, Djordjevic D, Young MR. Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors. Cancer Immunol Immunother 1998; 46: 253-260.